Docket Room.
SB 1724·MO·senate

Makes xylazine a Schedule III controlled substance

FailedFiled Feb 25, 2026
Sponsor: Justin Brown (R)
Latest Action

Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee

May 7, 2026

Email me when SB 1724 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 1724. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill repeals the current Section 195.017 and rewrites it to add xylazine as a Schedule III drug, limiting its possession and distribution to specific veterinary, research, and pharmaceutical exemptions. It would subject any xylazine‑containing product to the same controls as other Schedule III substances, affecting veterinarians, pharmacists, manufacturers, and anyone handling the drug. The measure failed after a second reading and referral to the Senate Judiciary and Civil and Criminal Jurisprudence Committee.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 1724

3 free questions a day, no account

History

  1. Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee
  2. S First Read

Sponsors

  • Justin Brown (R) · sponsor
  • Brown (16), Justin

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 1724 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 1724 free

Or ask your AI assistant about SB 1724 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice